ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,414Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 1442

$1.39M Total Retail Price of All Prescriptions

Rank: 7 out of 1442

1,526 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 15,248 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

48% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $75 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE-BENAZEPRIL 889 720 10 1 43
CRESTOR 724 591 2 10
METOPROLOL SUCCINATE 667 523 3 1
SIMVASTATIN 650 531 4 2
AMLODIPINE BESYLATE 643 537 5 3
LOSARTAN-HYDROCHLOROTHIAZIDE 600 496 6 30
ATORVASTATIN CALCIUM 554 408 7 4
BYSTOLIC 535 451 8 32
OMEPRAZOLE 535 424 8 21
CARVEDILOL 473 388 10 8
LISINOPRIL 458 357 11 7
DIOVAN HCT 434 405 12 35
ATENOLOL-CHLORTHALIDONE 421 356 10 13 119
TRIBENZOR 374 330 10 14 146
LOSARTAN POTASSIUM 372 287 15 13
FUROSEMIDE 354 304 16 5
METFORMIN HCL 349 258 17 26
DIOVAN 321 289 18 19
NEXIUM 314 264 19 34
RANEXA 302 260 20 29
EXFORGE 296 276 21 80
LABETALOL HCL 260 227 22 75
COREG CR 252 207 10 23 96
WARFARIN SODIUM 251 225 24 9
PLAVIX 247 230 25 14
PRADAXA 246 229 26 27
HYDROCHLOROTHIAZIDE 236 160 27 16
ZOLPIDEM TARTRATE 225 184 28 25
SPIRONOLACTONE 221 181 29 28
BENAZEPRIL HCL 201 140 30 88
CLOPIDOGREL 200 170 31 12
LOVAZA 196 133 32 37
JANUMET 193 151 33 109
MECLIZINE HCL 171 162 34 83
BISOPROLOL FUMARATE 159 112 35 60
LISINOPRIL-HYDROCHLOROTHIAZIDE 147 139 36 52
JANUVIA 147 138 36 45
BISOPROLOL-HYDROCHLOROTHIAZIDE 127 98 38 106
EFFIENT 124 96 39 98
DILTIAZEM 24HR CD 124 114 39 59
ONGLYZA 121 92 41 169
BENAZEPRIL-HYDROCHLOROTHIAZIDE 121 92 41 265
PRAVASTATIN SODIUM 120 98 43 20
MICARDIS HCT 116 108 44 142
EXFORGE HCT 114 99 45 151
ISOSORBIDE MONONITRATE ER 112 104 46 17
SPIRONOLACTONE-HCTZ 112 101 46 108
INDAPAMIDE 109 91 48 122
KOMBIGLYZE XR 96 74 49 283
LIPITOR 95 76 50 24
DIGOXIN 89 84 51 15
METOPROLOL TARTRATE 88 75 52 6
AZOR 88 74 52 133
DEXILANT 86 56 54 160
XARELTO 84 59 55 74
ADVAIR DISKUS 84 73 55 79
VALSARTAN-HYDROCHLOROTHIAZIDE 76 69 57 222
METOPROLOL-HYDROCHLOROTHIAZIDE 76 71 57 304
NAPROXEN 75 53 59 133
BENICAR HCT 75 60 59 86
MICARDIS 71 61 61 126
CLONIDINE HCL 69 62 62 66
ATENOLOL 67 55 63 11
GLYBURIDE-METFORMIN HCL 60 56 R 64 121
ENALAPRIL MALEATE 59 52 65 23
ZETIA 59 38 65 31
GLYBURIDE 56 47 R 67 105
MELOXICAM 55 44 68 92
LEVOTHYROXINE SODIUM 54 44 69 22
SINGULAIR 52 43 70 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 19, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.